Life Sciences Health Industry China Briefing

This post was written by Jay Yan, Mao Rong, Gordon Schatz and Abraham Sorock.

Reed Smith’s Life Sciences Health Industry China Briefing provides a summary of the monthly news and legal developments relating to China's Pharmaceutical, Food & Health Care Industries.
Some important developments during June include:

  • Chinese drug company to build production and training center in U.S.
  • Drug company challenged for environmental contamination in China
  • China's national biomedical plan to be released soon
  • Issuance of administrative measures for device recalls
  • Designation of four professional associations to examine Class III medical technology
  • Extension of Drug GMP certificates
  • Recall of an antibiotic

To read the full briefing by Reed Smith China team members, click here.

Vermont Modifies Manufacturer Gift Ban and Reporting Law, Effective July 1, 2011

This post was written by Elizabeth B. Carder-Thompson and Katie C. Pawlitz.

On May 26, 2011, Vermont Governor Peter Shumlin signed into law Senate Bill 104 (“S.104”), significantly modifying Vermont law banning the provision by manufacturers of gifts to health care providers and requiring disclosure of certain allowable expenditures and gifts to health care providers (18 V.S.A. § 4631a and 18 V.S.A. § 4632). S.104 follows amendments made to the Vermont gift ban and disclosure law enacted just last year. This Client Alert includes a summary of the modifications pursuant to S.104. Except as otherwise noted, the changes are effective July 1, 2011. To read the full Alert, click here.

This is a follow-up to our previous Client Alert "Update on Medical Device Manufacturer Marketing Activities: State and Federal Restrictions and Reporting Requirements," which provides a brief overview of the existing state marketing laws that apply to device manufacturers, including recent changes to those laws, as well as federal reporting requirements under the ACA.

Convergence of Communications and Medical Systems: The Opportunities and the Challenges

This post was written by Judy Harris, Amy Mushahwar and Areta Kupchyk.

The Federal Communications Commission (FCC) just announced that, as part of its implementation of the recently released National Broadband Plan and the Plan's recommendation to use the power of broadband to improve healthcare, the FCC and the Food and Drug Administration (FDA) are going to be holding a public meeting on July 26 and 27, 2010, to discuss regulatory issues arising from the convergence of wireless technology and healthcare devices.  The meeting is formally entitled: "Enabling the Convergence of Communications and Medical Systems: Ways to Update Regulatory and Information Processes."  The purpose of this meeting is, among other things, to discuss ways to promote investment and innovation in health technology by streamlining government processes.
 
To help develop an agenda for this important meeting, the FDA and the FCC are seeking input from, among others, the medical and device manufacturing industries, practitioners, and other stakeholders and users of medical technology on a number of questions regarding regulatory challenges and safety of patients and other users of medical devices that include radio elements and of systems that can be tied into broadband communications networks.  The information gathered will be used to enhance coordination between the FDA and the FCC for healthcare devices and applications and clarify the respective areas of expertise and jurisdiction between the agencies.  The solicitation of this information is intended to simplify and expedite the introduction of new medical technologies and devices.  

To this end, the FCC and the FDA have released a list of specific topics on which they are seeking input. Those topics are included in the Public Notice.

Commenters, however, are not limited to addressing the specific topics set forth, but rather should feel free to raise any issue of interest or concern.  The details of the two-day meeting at the end of July will be shaped by the comments received.  After those comments are reviewed, a final agenda for the meeting will be posted on the Internet.  

Comments are due June 25, so time is of the essence

Finally, the meeting will be open to the public and there will be an opportunity for interested parties to make oral presentations during any of the open comment sessions.  Preregistration to attend the meeting is desirable and required should you wish to speak.  The registration deadline is July 19th.

Please contact Judy Harris, Amy Mushahwar or Areta Kupchyk if you would like further information regarding these issues.